Shelby County Health Department Announces Mass COVID-19 Vaccination Enrollment

Print

Published on March 15 2021 3:02 pm
Last Updated on March 15 2021 3:02 pm
Written by Greg Sapp

Shelby County officials have announced Phase 1-B and 1-B+ Mass Vaccination Enrollment for J&J COVID-19 vaccine “Open ONLY to Residences and Workers of Shelby County, Illinois” The event will take place at Lake Shelbyville Visitors Center at 1989 State Hwy, Shelbyville, IL 62565 on Wednesday and Thursday, March 17-18 from 9:00 AM - 6:00 PM each day.

The Shelby County Health Department, the Illinois Department of Public Health and the Illinois National Guard announced open enrollment for residents of Shelby County and those individuals who work in Shelby County the opportunity to be vaccination against the Covid-19 disease with Johnson & Johnson’s one-dose vaccine.

A PHOTO ID IS MANDATORY - ONLINE REGISTRATION REQUIRED at: https://events.juvare.com/IL-IDPH/shelbynationalguard/

RESIDENCES MUST MEET ONE OF THE FOLLOWING CATEGORIES:

• Phase 1B: AGE 65 and Older and Essential Workers AGE 16 and Older

• Phase 1B includes frontline essential workers age 16 and older and residents age 65 and over to get vaccinated. The frontline essential workers designation includes many residents who carry a higher risk of COVID-19 exposure because of their work duties, often because they are unable to work from home, and/or they must work closely to others without being able to socially distance. This includes first responders, K-12 education workers, food and agriculture, manufacturing, Utility workers, corrections workers and inmates, USPS workers, public transit workers, grocery store workers and staff at shelters and day cares.

• Phase 1B+: AGE 16 and Older • Phase 1B+ includes vaccine eligibility to people in Illinois with serious medical conditions. The expanded list of eligible conditions include cancer, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), diabetes, heart conditions, immunosuppressed states from a solid organ transplant, smoking, obesity, pregnancy, pulmonary disease, and sickle cell disease. The expansion of Phase 1B+ will allow an additional 3.4 million people across Illinois to become eligible for the vaccine.